2026 NPPES data Allergy Physician NPI 1407884125 MD
Verify on CMS →

Mathew Varghese, MD

Allergy Physician in North Bergen, New Jersey.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 1,019 in Allergy Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
640
Medicare Part D claims · 120 beneficiaries · Allergy Physician avg: 755
Generic prescribing
73%
generic claims · 28% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$538.48
7 payments · CMS Open Payments (Sunshine Act)
Compiled from official public sources by the PlainDoctor editorial team.

What the federal data shows

Mathew Varghese, MD filed 640 Medicare Part D claims in 2023 as a Allergy Physician in North Bergen, New Jersey, prescribing 73% generic.

640
Part D claims, 2023
73%
generic prescribing
$538.48
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Mathew Varghese, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023, across all CMS prescribers nationally

640 Top 31% higher than 69% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). This entry sits in this band. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2K+: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic, not verified)

Mathew Varghese, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Mathew Varghese, MD?

Quality data not reported

NPI registry status

Active

Issued 06/29/2006

NPI 1407884125

Primary specialty

Allergy Physician

Niche

1,019 US NPIs in this specialty

Medicare Part D claims

640 15% vs specialty avg

2023 prescription claims

Specialty avg: 755

Specialty distribution in New Jersey

How Allergy Physician compares to other specialties among New Jersey providers

New Jersey providers
Mental Health Counselor - 6.2%Mental Health Counselor6.2%Physical Therapist - 5.9%Physical Therapist5.9%Clinical Social Worker - 5.5%Clinical Social Worker5.5%Student in an Organized Health Care Education/Training Program - 5.4%Student in an Organized Health Care Education/Training Program5.4%Pharmacist - 5%Pharmacist5%Internal Medicine Physician - 3.1%Internal Medicine Physician3.1%Allergy Physician - 0%Allergy Physician0%
Largest specialties in New Jersey (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Allergy Physician. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Mathew Varghese, MD appears in the CMS NPPES registry as a Allergy Physician provider holding MD credentials at 8901 KENNEDY BLVD STE 4SW, North Bergen, NJ, 07047, with a listed phone of (201) 374-1718. NPI 1407884125 was issued on 06/29/2006.

Medicare Part D records for calendar year 2023 show 640 prescription claims written by this provider, covering 120 Medicare beneficiaries and totaling roughly $167K in drug spend, split 28% brand-name and 73% generic by claim count.

Allergy Physician is a narrow specialty nationwide, with 1,019 enrolled providers across 49 states and an average of 755 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.

Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

8901 KENNEDY BLVD STE 4SW
North Bergen, NJ 07047

Provider Details

NPI 1407884125
Specialty Allergy Physician
Credentials MD
Gender Male
NPI Issued 06/29/2006

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Mathew Varghese, MD. Source: openpaymentsdata.cms.gov.

Total received

$538

Largest payer

GENZYME CORPORATION

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Above average

Mathew Varghese, MD - brand share 28.0%
Allergy Physician average

28% brand-name claims vs 73% generic, on 640 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

640
Total Claims
$167K
Total Drug Cost
120
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
760
Total Day Supply
20,631
Brand vs Generic
28% brand / 73% generic
Brand Drug Cost
$147K
Generic Drug Cost
$21K
Antibiotic Claims
31

Patient Demographics

Average Patient Age
71.1 years
Avg HCC Risk Score
1.11
Gender Split
72% female / 28% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What Mathew Varghese, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Azelastine Hcl
108
Fluticasone Propionate
89
Azelastine-Fluticasone
Azelastine/Fluticasone
49
Trelegy Ellipta
Fluticasone/Umeclidin/Vilanter
49
Albuterol Sulfate Hfa
Albuterol Sulfate
39
Hydroxyzine Hcl
38
Ammonium Lactate
35
Prednisone
29
Olopatadine Hcl
20
Symbicort
Budesonide/Formoterol Fumarate
20

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Allergy Physician Overview

How Mathew Varghese, MD fits within the Allergy Physician landscape nationally.

1,019
Allergy Physician Providers in US
49
States with Allergy Physician
755
Avg Claims per Provider

Mathew Varghese, MD's 640 claims are below the specialty average of 755.

Nearby Allergy Physician Providers in New Jersey

Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as Varghese.

Compare Allergy Physician nationally: see state-by-state distribution →

Before you book an appointment

Use this federal record as your verification checklist, not as a recommendation.

  • Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
  • Check the active license and any disciplinary history with the New Jersey medical board, federal registration is not a license check. Credential verification guide
  • Weigh a second option: compare this provider with a nearby Allergy Physician peer on Medicare volume and prescribing patterns. Compare providers

Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.

Frequently Asked Questions

What is Mathew Varghese, MD's specialty?
Mathew Varghese, MD specializes in Allergy Physician and practices in North Bergen, New Jersey. Credentials: MD.
How much does Mathew Varghese, MD prescribe under Medicare Part D?
In 2023, Mathew Varghese, MD wrote 640 Medicare Part D claims totaling $167K in drug costs for 120 beneficiaries.
Where is Mathew Varghese, MD located?
Mathew Varghese, MD is located at 8901 KENNEDY BLVD STE 4SW, North Bergen, NJ, 07047. Phone: (201) 374-1718.
What is Mathew Varghese, MD's NPI number?
Mathew Varghese, MD's National Provider Identifier (NPI) is 1407884125, issued on 06/29/2006.
Does Mathew Varghese, MD prescribe more brand-name or generic drugs?
Mathew Varghese, MD's prescribing is 28% brand-name and 73% generic drugs by claim count, with $147K in brand drug costs.
How many Allergy Physician providers are there in the US?
There are 1,019 Allergy Physician providers across 49 states in the US. The average Allergy Physician provider writes 755 Medicare Part D claims per year.
What drugs does Mathew Varghese, MD prescribe most often?
Based on 2023 Medicare Part D data, Mathew Varghese, MD's most frequently prescribed drugs include Azelastine Hcl, Fluticasone Propionate, Azelastine-Fluticasone. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Mathew Varghese, MD accept Medicare?
Mathew Varghese, MD appears in CMS Medicare data with 640 Part D claims and 120 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Mathew Varghese, MD's credentials?
Mathew Varghese, MD's NPI is 1407884125 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Compiled from official public sources by the PlainDoctor editorial team.